Comparison of magnetic resonance elastography and gadoxetate disodiumyenhanced magnetic resonance imaging for the evaluation of hepatic fibrosis

Investigative Radiology

Volumn 48, Issue 8, 2013, Pages 607-613

  Choi, Ye Ra ^a   Lee, Jeong Min ^a,b,c   Yoon, Jeong Hee ^a   Han, Joon Koo ^a,b   Choi, Byung Ihn ^a,b  

^a Department of Radiology ^*  (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

Gadoxetate disodium enhanced MRI; Hepatic fibrosis; Liver stiffness value; MR elastography

Indexed keywords

GADOXETIC ACID;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; ELASTOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; LIVER FIBROSIS; MAGNETIC RESONANCE ELASTOGRAPHY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RIGIDITY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STAGING;

EID: 84880316386     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e318289ff8f     Document Type: Article

References (42)

1. Rockey DC, Friedman SL. Hepatic fibrosis and cirrhosis. In: Boyer TD, Wright TL, Mann MP, eds. Zakim and Boyer's Hepatology. Vol 1. 5th ed. New York, NY: Elsevier; 2007:87-109.
2. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371:838-851.
3. Thein HH, Yi Q, Dore GJ, et al. Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and metaregression. Hepatology. 2008;48:418-431.
4. Asbach P, Klatt D, Schlosser B, et al. Viscoelasticity-based staging of hepatic fibrosis with multifrequency MR elastography. Radiology. 2010;257:80-86.
5. Salameh N, Larrat B, Abarca-Quinones J, et al. Early detection of steatohepatitis in fatty rat liver by using MR elastography. Radiology. 2009;253:90-97.
6. Huwart L, Peeters F, Sinkus R, et al. Liver fibrosis: Non-invasive assessment with MR elastography. NMR Biomed. 2006;19:173-179.
7. Wang Y, Ganger DR, Levitsky J, et al. Assessment of chronic hepatitis and fibrosis: Comparison of MR elastography and diffusion-weighted imaging. AJR Am J Roentgenol. 2011;196:553-561.
8. Huwart L, Sempoux C, Salameh N, et al. Liver fibrosis: Noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index. Radiology. 2007;245:458-466.
9. Rouviere O, Yin M, Dresner MA, et al. MR elastography of the liver: Preliminary results. Radiology. 2006;240:440-448.
10. Talwalkar JA, Yin M, Fidler JL, et al. Magnetic resonance imaging of hepatic fibrosis: Emerging clinical applications. Hepatology. 2008;47:332-342.
11. Kim BH, Lee JM, Lee YJ, et al. MR elastography for noninvasive assessment of hepatic fibrosis: Experience from a tertiary center in Asia. J Magn Reson Imaging. 2011;34:1110-1116.
12. Yin M, Talwalkar JA, Glaser KJ, et al. Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol. 2007;5: 1207-1213.
13. Katsube T, Okada M, Kumano S, et al. Estimation of liver function using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance imaging. Invest Radiol. 2011;46:277.
14. Cruite I, Schroeder M, Merkle EM, et al. Gadoxetate disodiumYenhanced MRI of the liver: Part 2, protocol optimization and lesion appearance in the cirrhotic liver. AJR Am J Roentgenol. 2010;195:29-41.
15. Gschwend S, Ebert W, Schultze-Mosgau M, et al. Pharmacokinetics and imaging properties of Gd-EOB-DTPA in patients with hepatic and renal impairment. Invest Radiol. 2011;46:556-566.
16. Motosugi U, Ichikawa T, Sou H, et al. Liver parenchymal enhancement of hepatocyte-phase images in Gd-EOB-DTPA-enhanced MR imaging: Which biological markers of the liver function affect the enhancement? J Magn Reson Imaging. 2009;30:1042-1046.
17. Huppertz A, Haraida S, Kraus A, et al. Enhancement of focal liver lesions at gadoxetic acidYenhanced MR imaging: Correlation with histopathologic findings and spiral CTVinitial observations. Radiology. 2005;234:468-478.
18. Yamada A, Hara T, Li F, et al. Quantitative evaluation of liver function with use of gadoxetate disodiumYenhanced MR imaging. Radiology. 2011;260:727-733.
19. Chen BB, Hsu CY, Yu CW, et al. Clinical and histologic implications of delayed hepatobiliary enhancement on magnetic resonance imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid. Invest Radiol. 2012;47: 649-655.
20. Watanabe H, Kanematsu M, Goshima S, et al. Staging hepatic fibrosis: Comparison of gadoxetate disodiumYenhanced and diffusion-weighted MR imagingVpreliminary observations. Radiology. 2011;259:142-150.
21. Manduca A, Oliphant T, Dresner M, et al. Magnetic resonance elastography: Non-invasive mapping of tissue elasticity. Med Image Anal. 2001;5:237-254.
22. Bedossa P, Bioulac-Sage P, Callard P, et al, for the French METAVIR Cooperative Study Group: Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology. 1994;20:15-20.
23. Rockey DC, Bissell DM. Noninvasive measures of liver fibrosis. Hepatology. 2006;43:S113-S120.
24. Zois C, Baltayiannis G, Karayiannis P, et al. Systematic review: Hepatic fibrosisYregression with therapy. Aliment Pharmacol Ther. 2008;28:1175-1187.
25. Ziol M, Handra-Luca A, Kettaneh A, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology. 2005;41:48-54.
26. Motosugi U, Ichikawa T, Muhi A, et al. Magnetic resonance elastography as a predictor of insufficient liver enhancement on gadoxetic acid-enhanced hepatocyte-phase magnetic resonance imaging in patients with type C hepatitis and Child-Pugh class A disease. Invest Radiol. 2012;47:566-570.
27. Ghany MG, Strader DB, Thomas DL, et al. Diagnosis, management, and treatment of hepatitis C: An update. Hepatology. 2009;49:1335-1374.
28. Kim AI, Saab S. Treatment of hepatitis C. Am J Med. 2005;118:808-815.
29. Dienstag JL. The role of liver biopsy in chronic hepatitis C. Hepatology. 2002;36:s152-s160.
30. Lok ASF, McMahon BJ. Chronic hepatitis B. Hepatology. 2001;34:1225-1241.
31. Motosugi U, Ichikawa T, Oguri M, et al. Staging liver fibrosis by using liverenhancement ratio of gadoxetic acid-enhanced MR imaging: Comparison with aspartate aminotransferase-to-platelet ratio index. Magn Reson Imaging. 2011;29:1047-1052.
32. Rousselet MC, Michalak S, Dupré F, et al. Sources of variability in histological scoring of chronic viral hepatitis. Hepatology. 2005;41:257-264.
33. Castera L. Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology. 2012;142:1293-1302.
34. Chow AM, Tan M, Gao DS, et al. Molecular MRI of liver fibrosis by a peptidetargeted contrast agent in an experimental mouse model. Invest Radiol. 2013;48:46-54.
35. Godfrey EM, Patterson AJ, Priest AN, et al. A comparison of MR elastography and 31P MR spectroscopy with histological staging of liver fibrosis. Eur Radiol. 2012;22:2790-2797.
36. Faria SC, Ganesan K, Mwangi I, et al. MR imaging of liver fibrosis: Current state of the art. Radiographics. 2009;29:1615-1635.
37. Venkatesh SK, Yin M, Glockner JF, et al. MR elastography of liver tumors: Preliminary results. AJR Am J Roentgenol. 2008;190:1534-1540.
38. Mariappan YK, Glaser KJ, Ehman RL. Magnetic resonance elastography: A review. Clin Anat. 2010;23:497-511.
39. Ng CS, Raunig DL, Jackson EF, et al. Reproducibility of perfusion parameters in dynamic contrast-enhanced MRI of lung and liver tumors: Effect on estimates of patient sample size in clinical trials and on individual patient responses. AJR Am J Roentgenol. 2010;194:W134-W140.
40. Bensamoun SF, Wang L, Robert L, et al. Measurement of liver stiffness with two imaging techniques: Magnetic resonance elastography and ultrasound elastometry. J Magn Reson Imaging. 2008;28:1287-1292.
41. Sandrin L, Fourquet B, Hasquenoph JM, et al. Transient elastography: A new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29:1705-1713.
42. Motosugi U, Ichikawa T, Sano K, et al. Magnetic resonance elastography of the liver: Preliminary results and estimation of inter-rater reliability. Jpn J Radiol. 2010;28:623-627.